20909 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Depsipeptides; Derivatives thereof
COMBINATION OF INOSITOL PHOSPHORYLCERAMIDE SYNTHETASE INHIBITOR AND AMPHOTERICIN B, AND USE THEREOF
#2PRECLINICAL DEVELOPMENT OF A ROMIDEPSIN NANOPARTICLE DEMONSTRATES SUPERIOR TOLERABILITY AND EFFICACY IN MODELS OF HUMAN T-CELL LYMPHOMA AND LARGE GRANULAR LYMPHOCYTE LEUKEMIA
#3HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES
#4HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY
#5DEPSIPEPTIDE AND USES THEREOF
#6METHOD FOR INDUCING IN-SITU REGENERATION OF MAMMAL AND USE THEREOF
#7METHODS FOR TREATING TUMORS
#8TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS USING NANO POLYMERS OF HISTONE DEACETYLASE INHIBITORS
#9METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS
#10COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID)
#11METHODS FOR TREATING A CORONAVIRUS INFECTION USING VALPROIC ACID AND DOCOSAHEXAENOIC ACID
#12NOVEL PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
#13DEPSIPEPTIDE-BASED AMPHIPHILIC BULIDING BLOCK TO INHIBIT PROTEIN-PROTEIN INTERACTIONS, NANOSTRUCTURE COMPRISED THEREOF AND USES THEREOF
#14G ALPHA Q/11 INHIBITORS FOR USE AS AN ANALGESIC
#15COMBINATION, COMPOSITION, AND METHOD OF ADMINISTERING THE COMBINATION OR COMPOSITION TO ANIMALS
#16p38 MAPK INHIBITORS AND USES THEREOF
#17PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES
#18METHODS FOR IMPROVING THE EFFICACY OF HDAC INHIBITOR THERAPY AND PREDICTING THE RESPONSE TO TREATMENT WITH HDAC INHIBITOR
#19PRISTINAMYCIN IA AND FLOPRISTIN COMBINATIONS IN TREATING OR PREVENTING BACTERIAL INFECTIONS
#20MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER
#21COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS
#22METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES
#23METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS
#24COMBINATIONAL THERAPY OF LSD1 INHIBITORS WITH P21 ACTIVATORS IN THE TREATMENT OF CANCER
#25METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS
#26ROMIDEPSIN AS A THERAPEUTIC AGENT FOR NERVE-INJURY INDUCED NEUROPATHIC PAIN AND SPASTICITY
#27PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING ANGIOGENESIS
#28PHARMACEUTICAL COMPOSITIONS COMPRISING TEIXOBACTIN
#29BIFUNCTIONAL CHEMICAL EPIGENENTIC MODIFIERS AND METHODS OF USE
#30A NOVEL COMPOUND ACTING AGAINST A SELECT GROUP OF BACTERIA
#31MULTILAYERED BLOOD PRODUCT
#32Process for the preparation of cyclic depsipeptides
#33METHODS OF TREATING HEMATOLOGICAL MALIGNANCY USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#34COMBINATION THERAPY FOR TREATING CANCER
#35COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID
#36METHODS FOR TREATING VIRAL DISORDERS
#37EPIGENETIC MODIFIERS TO TREAT RETINAL DEGENERATIONS
#38COMPOUNDS FOR USE IN INFLAMMATORY CONDITIONS
#39METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIA
#40METHODS OF TREATING SOLID TUMORS USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#41METHODS AND SYSTEMS FOR ENHANCING DELIVERY OF THERAPEUTIC AGENTS TO BIOFILMS USING LOW BOILING POINT PHASE CHANGE CONTRAST AGENTS
#42COMBINATION THERAPY OF LYMPHOMA
#43Histone acetyltransferase activators and compositions and uses thereof
#44COMPOUNDS FOR USE IN VIRAL INFECTIONS
#45COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONS
#46PLD FOR USE IN COMBINATION IN THE TREATMENT OF CORONAVIRUS
#47COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION
#48HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY
#49TARGETED PHARMACOLOGICAL THERAPEUTICS IN UVEAL MELANOMA
#50Compounds with Antimicrobial Properties
#51PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF
#52METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS
#53TOPICAL PHARMACEUTICAL FORMULATIONS OF A CYCLIC DEPSIPEPTIDE
#54Pharmaceutical Compositions Comprising an Inhibitor of a Histon-deacetylase (HDACi) and an Agonist of Toll-like-receptor 7 and/or 8 (TLR7 and/or TLR8) and Their Use in the Treatment of Cancer
#55Endoparasitic depsipeptides
#56Depsipeptide and uses thereof
#57ANTIBODIES THAT BIND TO LRP6 PROTEINS AND METHODS OF USE
#58A TEIXOBACTIN ANALOGUE AND USE THEREOF
#59INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#60Methods and compositions for treating viral or virally-induced conditions
#61METHODS OF TREATING VIRALLY ASSOCIATED CANCERS WITH HISTONE DEACETYLASE INHIBITORS
#62Endoparasitic depsipeptides
#63COMPOSITIONS AND METHODS FOR TREATING NEUROBLASTOMA
#64Use of fungal cyclic peptides of the destruxin type as antibacterial agents active against Clostridium perfringens
#65HISTONE ACETYLTRANSFERASE (HAT) REGULATORS AND USES THEREOF
#66METHODS FOR TARGETED TREATMENT AND PREDICTION OF PATIENT SURVIVAL IN CANCER
#67Anthelmintic depsipeptide compounds
#68METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE PREVENTION OF RECURRENT INFECTIONS CAUSED BY CLOSTRIDIUM DIFFICILE
#69Compositions and methods for reactivating latent immunodeficiency virus
#70TREATMENT OF ADULT T CELL LEUKEMIA/LYMPHOMA (ATLL) USING MIR-155 INHIBITORS
#71THIOESTER PRODRUGS OF MACROCYCLES AS INHIBITORS OF HISTONE DEACETYLASES
#72Treating Intraocular Retinoblastoma with Inhibitors of Histone Modification
#73Process for the preparation of cyclic depsipeptides
#74COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS
#75DELIVERY OF CYCLIC COMPOUND BY USING CARRIER
#76Bifunction chemical epigenetic modifiers and methods of use
#77Processes for preparing functionalized cyclooctenes
#78NOVEL ANTI-CANCER COMBINATION AND A METHOD OF THERAPY USING THE COMBINATION
#79NOVEL HYDROGEL CONJUGATES
#80Platinum-acridine compounds and methods of treating cancers
#81Methods and apparatuses for treating tumors
#82ENHANCEMENT OF ANTIBACTERIAL ACTIONS OF A DEPSIPEPTIDE ANTIBIOTIC USING SYNERGISTIC AMOUNTS OF BORIC ACID
#83Cryptophycin antibody conjugates for the treatment of cancer
#84CANCER THERAPY VIA A COMBINATION OF EPIGENETIC MODULATION AND IMMUNE MODULATION
#85Method for the synthesis of cyclic depsipeptides
#86Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#87Combination, composition, and method of administering the combination or composition to animals
#88Combination therapy for treating cancer
#89Use of a combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer
#90Multilayered blood product
#91NOVEL ANTIBIOTICS AND METHODS OF USING THEM
#92Pharmaceutical compositions comprising teixobactin
#93ANGIOGENESIS INHIBITOR AND SCREENING METHOD FOR ANGIOGENESIS INHIBITORS
#94Anti-infective compound
#95Use of histone methyltransferase inhibitors and histone deacetylase inhibitors for therapy of Phelan-McDermid Syndrome
#96Bromodomain and extra-terminal protein inhibitor combination therapy
#97METHODS FOR TREATING CANCER AND PROTECTING RENEWABLE TISSUES
#98PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#99Anthelmintic depsipeptide compounds
#100Process for the preparation of cyclic depsipeptides
#101Multilayered blood product
#102Histone acetyltransferase activators and compositions and uses thereof
#103Thioester prodrugs of macrocycles as inhibitors of histone deacetylases
#104Method for treating ocular diseases
#105Compounds, compositions and methods for prevention and/or treatment of cancer
#106Endoparasitic depsipeptides
#107TARGETED PHARMACOLOGICAL THERAPEUTICS IN UVEAL MELANOMA
#108METHODS FOR TREATING CUTANEOUS T-CELL LYMPHOMA (CTCL) WITH MIR-155 INHIBITORS
#109SUBSTITUTED UREA DEPSIPEPTIDE ANALOGS AS ACTIVATORS OF THE CLPP ENDOPEPTIDASE
#110Combination therapy of lymphoma
#111COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS
#112Combination therapies of HDAC inhibitors and PD-1 inhibitors
#113Bromodomain and extra-terminal protein inhibitor combination therapy
#114METHODS FOR TREATING CANCER
#115NOVEL PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
#116Combination HIV therapeutic
#117NOVEL PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF PERIODONTAL DISEASE
#118Cryptophycin antibody conjugates for the treatment of cancer
#119Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
#120Depsipeptide and uses thereof
#121Methods for treating viral disorders
#122Silstatin compounds
#123TARGETING OF INTERFERON-STIMULATED GENE EXPRESSION TO TREAT INTERFERONOPATHIES
#124Pharmaceutical composition for anti-angiogenesis containing cyclic pentadepsipeptide as an effective ingredient
#125Combination, composition, and method of administering the combination or composition to animals
#126Compositions and methods for reactivating latent immunodeficiency virus
#127Inhibitors of cytoplasmic histone deacetylase 4 complex for treating or preventing vascular or valve calcification
#128Anthelmintic depsipeptide compounds
#129PPAR-γ activators, HDAC inhibitors and their therapeutical usages
#130HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES
#131CD47 blockade therapy by HDAC inhibitors
#132Anthelmintic depsipeptide compounds
#133Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#134Increasing ATOH1 life to drive sensorineural hair cell differentiation
#135Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
#136Process for the preparation of cyclic depsipeptides
#137METHODS OF TREATING HEMATOLOGICAL MALIGNANCY USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#138Method of treatment of breast or colon cancer by administering muscle stimulated myokines
#139Antimicrobial compositions
#140Methods and compositions for treating viral or virally-induced conditions
#141Bromodomain and extra-terminal protein inhibitor combination therapy
#142Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
#143NOVEL PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
#144Combination therapies of HDAC inhibitors and PD-1 inhibitors
#145SNS-595 AND METHODS OF USING THE SAME
#146METHODS FOR PREDICTING CANCER PATIENT'S CLINICAL RESPONSE TO ANTI-CANCER COMPOUNDS
#147Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma
#148MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF
#149Drug Combinations For the Treatment of HIV
#150Anti-infective compound
#151CYCLIC DEPSIPEPTIDE COMPOUNDS AND THEIR USES
#152Preparations containing amorphous emodepside
#153DOSAGE REGIMEN FOR HIV VACCINE
#154Combination HIV therapeutic
#155Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
#156Bromodomain and extra-terminal protein inhibitor combination therapy
#157Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
#158Combination therapy with an antitumor alkaloid
#159COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID
#160Method of Vaccination Comprising a Histone Deacetylase Inhibitor
#161Histone acetyltransferase activators and compositions and uses thereof
#162COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID
#163Compositions and methods for reactivating latent immunodeficiency virus
#164SNS-595 AND METHODS OF USING THE SAME
#165Combination therapies of HDAC inhibitors and PD-1 inhibitors
#166Binding molecules, especially antibodies, binding to L1CAM (CD171)
#167Anthelmintic depsipeptide compounds
#168Macrocyclic inhibitors of flaviviridae viruses
#169Macrocyclic inhibitors of flaviviridae viruses
#170Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections
#171PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE
#172BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY
#173METHOD FOR REDUCING AND/OR DELAYING PATHOLOGICAL EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS I (HIV) OR FOR REDUCING THE RISK OF DEVELOPING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
#174Methods for producing a depsipeptide
#175PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#176Combination, composition, and method of administering the combination or composition to animals
#177Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent
#178METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS
#179METHODS OF TREATMENT OF C. DIFFICILE SPORES WITH RAMOPLANIN
#180Anthelmintic combinations and methods of use thereof
#181Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#182Cyclic peptide analogs and conjugates thereof
#183Romidepsin formulations and uses thereof
#184Cyclic depsipeptide compounds and their uses
#185Romidepsin formulations and uses thereof
#186ROMIDEPSIN FORMULATIONS AND USES THEREOF
#187HEXADEPSIPEPTIDE ANALOGUES AS ANTICANCER COMPOUNDS
#188Method for forming an immune-tolerant site and method for attracting immunosuppressive cells
#189Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
#190Compound, Transitmycin, Effective Against Bacterial and Viral Pathogens
#191Cancer therapy via a combination of epigenetic modulation and immune modulation
#192PSMA binding ligand-linker conjugates and methods for using
#193BRIDGE-HELIX CAP: TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE
#194Romidepsin formulations and uses thereof
#195Romidepsin formulations and uses thereof
#196MACROCYCLIC THERAPEUTIC AGENTS AND METHODS OF TREATMENT
#197Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#198Therapeutic peptides
#199Enopeptins, uses thereof, and methods of synthesis thereto
#200INHIBITION OF DRUG RESISTANT CANCER CELLS
#201Macrocyclic inhibitors of viruses
#202METHODS FOR TREATING EPSTEIN-BARR VIRUS (EBV) ASSOCIATED CANCERS USING ORAL FORMULATIONS OF 5-AZACYTIDINE
#203IN VIVO PHOTOACOUSTIC AND PHOTOTHERMAL NANO-THERANOSTICS OF BIOFILMS
#204METHODS FOR TREATING VIRAL DISORDERS
#205TREATMENT OF LATENT HIV INFECTION
#206Depsipeptide and uses thereof
#207Pharmaceutical formulations and their use in the treatment of periodontal disease
#208Macrocyclic inhibitors of flaviviridae viruses
#209COMBINATION THERAPY FOR HEMATOLOGICAL MALIGNANCIES
#210DAPTOMYCIN INJECTABLE FORMULATION
#211METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS
#212JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT
#213Cyclic pentadepsipeptide derivative and fusarium strain producing the same
#214SNS-595 and methods of using the same
#215Deacetylase inhibitor therapy
#216ROMIDEPSIN FORMULATIONS AND USES THEREOF
#217SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE
#218Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer
#219ROMIDEPSIN FORMULATIONS AND USES THEREOF
#220Cyclic pentadepsipeptides and microorganism of strain producing the same
#221Macrocyclic compounds useful as inhibitors of histone deacetylases
#222BEAUVERICIN COMPOSITIONS AND METHODS THEREOF FOR INHIBITING THE HSP90 CHAPERONE PATHWAY
#223Preparations containing amorphous emodepside
#224FORMULATIONS COMBINING RAMOPLANIN AND RHAMNOLIPIDS FOR COMBATING BACTERIAL INFECTION
#225Anti-biofilm compositions and methods for using
#226Resistance biomarkers for HDAC inhibitors
#227Treatments for
#228Method of vaccination comprising a histone deacetylase inhibitor
#229Suspension type topical formulations comprising cyclic depdipeptide
#230Inhibition of drug resistant cancer cells
#231Enopeptins, uses thereof, and methods of synthesis thereto
#232Macrocyclic therapeutic agents and methods of treatment
#233Methods for treating viral disorders
#234Macrocyclic inhibitors of viruses
#235Macrocyclic inhibitors of flaviviridae viruses
#236ROMIDEPSIN FORMULATIONS AND USES THEREOF
#237USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7
#238METHODS OF CARDIOVASCULAR PATIENT TREATMENT USING SUBSTANCES SUFFICIENT TO REDUCE ACTIN DEPOLYMERIZATION
#239Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#240CANCER TREATMENT METHOD
#241GEMCITABINE COMBINATION THERAPY
#242Suspension type topical formulations comprising cyclic depsipeptide
#243OIL-BASED PREPARATION
#244METHOD FOR TREATING OR AMELIORATING MUCOCUTANEOUS OR OCULAR TOXICITIES
#245Therapy for MLL-rearranged leukemia
#246Anti-biofilm compositions and methods for using
#247COMPOSITIONS FOR POTENTIATING APOPOSIS SIGNALS IN TUMOUR CELLS
#248SNS-595 and methods of using the same
#249APRATOXIN THERAPEUTIC AGENTS: MECHANISM AND METHODS OF TREATMENT
#250ENZASTAURIN FOR THE TREATMENT OF CANCER
#251CANCER THERAPY
#252Novel Cyclic Pentadepsipeptide Derivative and Fusarium Strain Producing The Same
#253SNS-595 AND METHODS OF USING THE SAME
#254Methods and Compositions for Treating Viral or Virally-Induced Conditions
#255COMPOSITIONS OF A V-ATPASE INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID RECEPTOR LIGAND AND METHODS OF USE
#256Treatment of cancers characterized by chromosomal rearrangement of the gene
#257CYCLIC DEPSIPEPTIDE COMPOUND AND USE THEREOF
#258COMBINATION OF AMIDINE DERIVATIVES WITH CYCLIC DEPSIPEPTIDES
#259CANCER TREATMENT METHOD
#260Multilayered blood product
#261MACROCYCLIC COMPOUNDS, PROTEASE INHIBITION, AND METHODS OF TREATMENT
#262Controlling diseases caused by trichomonadida
#263Device for regeneration of articular cartilage and other tissue
#264Controlling giardiosis
#265Use of cyclic depsipeptides to inhibit kallikrein 7
#266METHODS FOR TREATING VIRAL DISORDERS
#267Production and use of antitumoral cyclodepsipeptides
#268SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE
#269METHODS FOR INCREASING LEVELS OF HUMAN FETAL HEMOGLOBIN
#270Antitumoral Treatments
#271Anticancer Treatments
#272ANTITUMORAL TREATMENTS
#273Improved Antitumoral Treatments
#274Antitumoral Treatments
#275Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth
#276ACCELERATED THERAPY
#277HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM
#278GEMCITABINE COMBINATION THERAPY
#279ROMIDEPSIN-BASED TREATMENTS FOR CANCER
#280Use of Aplidine for the Treatment of Pancreatic Cancer
#281Treatment of Ras-expressing tumors
#282APLIDINE TREATMENT OF CANCERS
#283Combination of a) N--4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia
#284Injectable formulation of antibiotic and solution for intravenous administration thereof
#285Antitumoral treatments
#286Antitumoral Treatments
#287Antitumor agents
#288Preventing Vertical Endoparasite Infections
#289FK 228 derivates as HDAC inhibitors
#290Methods of treating infection
#291Combination therapy
#292DEPSIPEPTIDE-CONTAINING INJECTION SOLUTION
#293Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same
#294Endoparasiticidal Compositions
#295Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors
#296Deacetylase inhibitor therapy
#297Novel Depsipeptides and Process for Preparing Same
#298HISTONE DEACETYLASE INHIBITORS FOR TREATING DEGENERATIVE DISEASES OF THE EYE
#299Methods for the prevention and/or treatment of peripheral arterial disease
#300COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISORDERS